Munafa Stock Market Course + Intraday & FNO calls 
Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Karyopharm Therapeutics (KPTI)
Technical Analysis Report for USA stock KPTI Karyopharm Therapeutics. Dated: 11 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock KPTI Karyopharm Therapeutics then click here. or read Experts views on Karyopharm Therapeutics or Forecast & share price targets of Karyopharm Therapeutics
Karyopharm Therapeutics Opened at 1.50 and Closed at: 1.61, which is -0.62% of previous session's close. It moved within a range of 1.24 and 1.61
The session was a Bullish session with an average volume of 6737600, which is 88.11% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 1.43 and resistance for tomorrow is 1.8
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.36, 1.12 resistance for tomorrow's hourly charts is 1.73, 1.86
10 Day SMA for Karyopharm Therapeutics (KPTI) is 1.78 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Karyopharm Therapeutics (KPTI) is 1.85 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Karyopharm Therapeutics (KPTI) is 4.57 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 6.76 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Karyopharm Therapeutics is 7.07 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Karyopharm Therapeutics is at 1.85 and 200 DMA is at 7.07, while 50 DMA and 100 DMA are at 4.57 and 6.76 respectively
Karyopharm Therapeutics (KPTI) moving average of 20 SMA is at 1.85 and 20 EMA is at 2.12
| Date | Closing Price | 20 SMA | 20 EMA |
| 11 Fri Sep | 1.61 | 1.85 | 2.12 |
| 10 Thu Sep | 1.62 | 1.87 | 2.17 |
| 09 Wed Sep | 1.69 | 1.89 | 2.23 |
| 08 Tue Sep | 1.72 | 1.91 | 2.29 |
| 04 Fri Sep | 1.79 | 1.92 | 2.35 |
| 03 Thu Sep | 1.77 | 1.94 | 2.41 |
Karyopharm Therapeutics (KPTI) moving average of 50 SMA is at 4.57 and 50 EMA is at 3.91
| Date | Closing Price | 50 SMA | 50 EMA |
| 11 Fri Sep | 1.61 | 4.57 | 3.91 |
| 10 Thu Sep | 1.62 | 4.73 | 4 |
| 09 Wed Sep | 1.69 | 4.89 | 4.1 |
| 08 Tue Sep | 1.72 | 5.05 | 4.2 |
| 04 Fri Sep | 1.79 | 5.22 | 4.3 |
| 03 Thu Sep | 1.77 | 5.39 | 4.4 |
Karyopharm Therapeutics (KPTI) moving average of 100 SMA is at 6.76 and 100 EMA is at 5.48
| Date | Closing Price | 100 SMA | 100 EMA |
| 11 Fri Sep | 1.61 | 6.76 | 5.48 |
| 10 Thu Sep | 1.62 | 6.84 | 5.56 |
| 09 Wed Sep | 1.69 | 6.91 | 5.64 |
| 08 Tue Sep | 1.72 | 6.99 | 5.72 |
| 04 Fri Sep | 1.79 | 7.05 | 5.8 |
| 03 Thu Sep | 1.77 | 7.12 | 5.88 |
Karyopharm Therapeutics (KPTI) moving average of 200 SMA is at 7.07 and 200 EMA is at 6.23
| Date | Closing Price | 200 SMA | 200 EMA |
| 11 Fri Sep | 1.61 | 7.07 | 6.23 |
| 10 Thu Sep | 1.62 | 7.09 | 6.28 |
| 09 Wed Sep | 1.69 | 7.11 | 6.33 |
| 08 Tue Sep | 1.72 | 7.13 | 6.38 |
| 04 Fri Sep | 1.79 | 7.15 | 6.43 |
| 03 Thu Sep | 1.77 | 7.17 | 6.48 |
Xtl Biopharmaceuticals has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 11.73% more returns!
United Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in United Therapeutics, about 19.78% more returns!
Karyopharm Therapeutics has performed better than China Sxt in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Petmed Express has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Petmed Express, about 10.46% more returns!
Nucana Plc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Nucana Plc, about 3.32% more returns!
Macrogenics Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Macrogenics Inc, about 15.09% more returns!
Medpace Holdings has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Medpace Holdings, about 21.86% more returns!
Iradimed Corporation has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 14.86% more returns!
Iovance Biotherapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 43.51% more returns!
Insmed Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Insmed Inc, about 24.88% more returns!
Dbv Technologies has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Dbv Technologies, about 4.82% more returns!
Karyopharm Therapeutics has performed better than Curis Inc in short term. Holding Karyopharm Therapeutics could be a better choice for now!
Corcept Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Corcept Therapeutics, about 18.83% more returns!
Collplant Holdings has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Collplant Holdings, about 980.91% more returns!
Aytu Bioscience has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Aytu Bioscience, about 3.91% more returns!
Aldeyra Therapeutics has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Aldeyra Therapeutics, about 6.2% more returns!
Penumbra Inc has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Penumbra Inc, about 17.46% more returns!
Novartis Ag has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Novartis Ag, about 11.21% more returns!
Iqvia Holdings has performed better than Karyopharm Therapeutics in short term. You could have earned much better returns by investing in Iqvia Holdings, about 30.91% more returns!
Karyopharm Therapeutics Technical analysis of indicators
Price action analysis of Karyopharm Therapeutics (KPTI) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Karyopharm Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Karyopharm Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Karyopharm Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Karyopharm Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Karyopharm Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.74 and Karyopharm Therapeutics KPTI stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Karyopharm Therapeutics KPTI stock. Volume based technical analysis of Karyopharm Therapeutics KPTI stock is negative.
Karyopharm Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock KPTI Karyopharm Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And KPTI Experts View which covers a lot of information including buying and selling signals
KPTI future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Karyopharm Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Karyopharm Therapeutics (KPTI) Technical (Analysis) Reports Karyopharm Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
